Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Public Health. 2006 Jul;96(7):1308-13. Epub 2006 May 30.

Impact of state vaccine financing policy on uptake of heptavalent pneumococcal conjugate vaccine.

Author information

  • 1National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Ga 30333, USA. sstokley@cdc.gov

Abstract

OBJECTIVE:

We examined heptavalent pneumococcal conjugate vaccine (PCV7) uptake among children aged 19 to 35 months in the United States and determined how uptake rates differed by state vaccine financing policy.

METHODS:

We analyzed data from the 2001-2003 National Immunization Survey. States that changed their vaccine financing policy between 2001 and 2003 (n=17) were excluded from analysis. Logistic regression was performed to identify the association between state vaccine financing policy and receipt of 3 or more doses of PCV7 after control for demographic characteristics.

RESULTS:

The proportion of children receiving 3 or more doses increased from 6.7% in 2001 to 69.0% in 2003. After controlling for demographic characteristics, children residing in states that provided all vaccines except PCV7 to all children had lower odds of receiving 3 or more doses compared to children residing in states that provided PCV7 only to children eligible for the Vaccines for Children program (odds ratio=0.58; 95% confidence interval=0.51, 0.66).

CONCLUSION:

It is essential that we continue to monitor the effect that state vaccine financing policy has on the delivery of PCV7 and future vaccines, which are likely to be increasingly expensive.

PMID:
16735626
[PubMed - indexed for MEDLINE]
PMCID:
PMC1483861
Free PMC Article

Images from this publication.See all images (1)Free text

FIGURE 1—
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk